ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Learning and Behavior Problems in Children With Chronic Granulomatous Disease and Related Disorders

This study has been completed.

Sponsored by: National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by: National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier: NCT00005933
  Purpose

This study will try to determine what causes learning, behavioral and emotional problems in children with chronic granulomatous disease (GCD) and other phagocyte disorders. (Phagocytes are a type of white blood cell.) Children with these disorders have frequent severe infections that require hospitalization, sometimes for long periods of time. Many of them also have problems with school, learning, behavior, anxiety and depression. This study will explore whether these latter problems are a direct result of the illness itself or are a consequence of frequent, long hospitalizations, or are due to other factors. Test findings in these children will be compared with those of children with cystic fibrosis-another disease that causes frequent infections requiring prolonged hospitalization.

Patients age 2 or older with GCD or other phagocytic disorders or cystic fibrosis may be eligible for this study. Participants (or a parent or guardian) will complete questionnaires including personal information such as age, gender and marital status, a family medical history, and information on their illness. Patients will be given various psychological and intelligence tests, and they and their parents or guardians will be interviewed by a child psychiatrist. The tests and interviews take a total of about 5 hours and are given in two or three separate sessions.

The tests may reveal problems such as learning disorders, attention-deficit hyperactivity disorder, anxiety, or depression. If any of these problems are identified, appropriate referrals will be made for specialized services, such as special school placement, tutoring, or counseling.


Condition
Chediak Higashi Syndrome
Chronic Granulomatous Disease
Job's Syndrome
Leukocyte Disorder

Genetics Home Reference related topics:   Chediak-Higashi syndrome    Job syndrome    L1 syndrome   

U.S. FDA Resources

Study Type:   Observational
Official Title:   Cognitive Function in Leukocyte Disorders

Further study details as provided by National Institutes of Health Clinical Center (CC):

Estimated Enrollment:   150
Study Start Date:   June 2000
Estimated Study Completion Date:   July 2005

Detailed Description:

Leukocyte disorders are predominantly genetic diseases in which phagocytes fail to function normally resulting in recurrent infections. Children with these disorders are subject to recurrent, severe, often life-threatening infections and are hospitalized more frequently than their peers. Frequent hospitalization and chronic illness can affect growth, development, socialization, and educational opportunities.

Specifically, chronic granulomatous disease (CGD) is an inherited disorder in which phagocytes fail to generate an oxidative burst. In 26 patients followed at the NIH tested for behavioral problems at the request of a parent or staff member, we have observed a 23% rate of mild mental retardation. However, it is not clear whether this is due to CGD per se or the recurrent infections and hospitalizations. We seek to determine the prevalence of cognitive disabilities in children with CGD and other leukocyte disorders. We seek to determine whether abnormal leukocyte functioning may be related to specific behavioral phenotypes or impaired cognitive functioning. We also seek to clarify whether impaired cognitive functioning is related to the effects of frequent and prolonged hospitalization or other variables such as severity of illness in this population.

  Eligibility
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

INCLUSION CRITERIA

Presence of a confirmed diagnosis of CGD or other phagocytic disorder.

Age 2 or older.

English spoken in the home.

EXCLUSION CRITERIA

Unconfirmed phagocytic disorder.

Under age 2.

First language is other than English.

  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00005933

Locations
United States, Maryland
National Institute of Allergy and Infectious Diseases (NIAID)    
      Bethesda, Maryland, United States, 20892

Sponsors and Collaborators
  More Information


Publications:

Study ID Numbers:   000164, 00-I-0164
First Received:   July 4, 2000
Last Updated:   March 3, 2008
ClinicalTrials.gov Identifier:   NCT00005933
Health Authority:   United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
Chronic Disease  
Pediatric  
Pulmonary  
Intelligence  
Coping
Chronic Illness
Learning

Study placed in the following topic categories:
Job syndrome
Job's Syndrome
Genetic Diseases, Inborn
Hematologic Diseases
Granulomatous Disease, Chronic
Genetic Diseases, X-Linked
Chronic Disease
Leukocyte Disorders
Chediak-Higashi syndrome
Chronic granulomatous disease
Chediak-Higashi Syndrome
Immunologic Deficiency Syndromes

Additional relevant MeSH terms:
Phagocyte Bactericidal Dysfunction
Pathologic Processes
Disease
Immune System Diseases
Syndrome

ClinicalTrials.gov processed this record on December 03, 2008




Links to all studies - primarily for crawlers